Centauri Health Solutions Acquires MedAllies, Broadens Health Data Network to Support Mission Critical Use Cases

Transaction adds 1,000 hospitals, 5,000 ambulatory organizations, and 125,000 healthcare providers to industry-leading nationwide clinical exchange network

Centauri Health Solutions (“Centauri”), a Phoenix, Arizona-based health information technology company, announced its acquisition of MedAllies, a New York-based Health Information Service Provider (HISP) and Qualified Health Information Network® (QHIN™) focused on health data connectivity and clinical data exchange.

A trailblazer in healthcare interoperability, MedAllies serves more than 1,000 hospitals/health systems, 5,000 ambulatory organizations, and 125,000 healthcare providers, ensuring the secure and seamless transmission of critical health information through national networks. This acquisition boosts Centauri’s solutions with industry-leading integration, messaging, and record location services, enhancing access to care and financial support for patients, especially the most vulnerable.

“Centauri is the perfect partner for MedAllies. Our shared vision for interoperability and bi-directional exchange is essential to advancing healthcare,” said Dr. John Blair, CEO of MedAllies. “We are excited to offer our clients the broadest clinical exchange network to support mission critical use cases.”

Mike McNelis, Centauri co-founder and CEO, added, “The addition of MedAllies strengthens our commitment to intelligently deliver clinical data solutions in a manner and form that facilitates value creation and empowers shared risk initiatives. Connecting the MedAllies HISP and best-in-class Care Enabled Network/QHIN with Centauri’s network and AI solutions offers significant value to all our clients.”

The acquisition was supported by Centauri’s lead investor, Abry Partners, along with Silversmith Capital Partners and SV Health Investors. Santander served as the financial advisor to MedAllies with HunterMaclean as legal counsel. Kirkland and Ellis was legal counsel to Centauri for the transaction.

About Centauri Health Solutions

Centauri Health Solutions offers technology-enabled solutions to health systems and health plans for various healthcare programs including Medicare, Medicaid, Commercial and Exchange. Through collaboration with clients, we improve the lives and health outcomes of patients and members through compassionate outreach, sophisticated analytics, and intelligent clinical data delivery. Centauri addresses market issues such as uncompensated care in health systems; risk-adjusted revenue for specialized populations; and enhances access to and quality of care measurement. Headquartered in Phoenix, Arizona, Centauri Health Solutions employs 1,500 associates nationwide. Centauri has been listed on the Inc. 5000 from 2019-2022, and the 2020 Deloitte Technology Fast 500™ list. More details can be found at www.centaurihs.com.

About Abry Partners

Abry Partners is one of the most experienced and successful sector-focused private equity investment firms in North America. Since its founding in 1989, the firm has completed over $90 billion of leveraged transactions and other private equity or preferred equity placements. Currently, the firm manages over $5.0 billion of capital across its active funds. For more information about Abry Partners, visit www.abry.com.

About Silversmith Capital Partners

Founded in 2015, Silversmith Capital Partners is a Boston-based growth equity firm with $3.3 billion of capital under management. Silversmith’s mission is to partner with and support the best entrepreneurs in growing, profitable technology and healthcare companies. Representative investments include ActiveCampaign, Appfire, Apryse, DistroKid, impact.com, Iodine Software, LifeStance Health, Onbe, and Webflow. For more information, including a full list of portfolio investments, visit www.silversmith.com or follow the firm on LinkedIn.

About SV Health Investors

SV Health Investors (“SV”) is a private equity firm dedicated to investments in the healthcare and life sciences sector. Founded in 1993, with offices in Boston and London, SV manages >$2.0 billion across multiple investment strategies. SV’s dedicated healthcare growth-buyout strategy seeks to partner with experienced management teams to accelerate the success of innovative healthcare companies across outsourced services, life sciences and medical products, tech-enabled healthcare services, and healthcare information technology. Over the past 30+ years, SV has invested in 250+ healthcare companies. For more information about SV, visit www.svhealthinvestors.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250424476310/en/

“The addition of MedAllies strengthens our commitment to intelligently deliver clinical data solutions in a manner and form that facilitates value creation and empowers shared risk initiatives." - Mike McNelis, Centauri Co-Founder and CEO